(Q28193370)

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Results of CURE trial for acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Combination therapy with clopidogrel and aspirin after coronary stenting.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Clopidogrel versus ticlopidine after intracoronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Clopidogrel as adjunctive antiplatelet therapy during coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

The antiplatelet effects of ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Platelet inhibitors and bleeding in cardiac surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Coronary artery bypass graft in abciximab-treated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Clinical experience in coronary bypass surgery for abciximab-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Amelioration of the bleeding tendency of preoperative aspirin after aortocoronary bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Aprotinin counterbalances an increased risk of peri-operative hemorrhage in CABG patients pre-treated with Aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

The platelet in cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Aprotinin reduces clopidogrel-induced prolongation of the bleeding time in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Aspirin use and survival after coronary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Aspirin does not increase homologous blood requirements in elective coronary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Hemostatic function of aspirin-treated platelets vulnerable to cardiopulmonary bypass. Altered shear-induced pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021

Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901954-X

7 January 2021